[Study of cellular immunity and the opioid peptide system in patients  with multiple sclerosis]

Author(s): Demina TL, BoÄ­ko AN, Rossel's AN, Balashov KE, Popova NF 


Twenty-five patients with chronic progressing multiple sclerosis were examined for the content of beta-endorphin in blood serum, supernatants of activated lymphocytes and CSF by RIA. At the same time the parameters of cellular immunity were appraised. Different relations were discovered between cellular immunity and the content of beta-endorphin in biological fluids which may play a material part in the pathogenesis of multiple sclerosis.

Similar Articles

SOD1 and amyotrophic lateral sclerosis: mutations and  oligomerization

Author(s): Banci L, Bertini I, Boca M, Girotto S, Martinelli M, et  al.

Oral treatment  for multiple sclerosis

Author(s): Killestein J, Rudick RA, Polman CH

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple  sclerosis (MS)

Author(s): Constantinescu CS, Farooqi N, O'Brien K, Gran B

Variable effects of cyclophosphamide in rodent models of  experimental allergic encephalomyelitis

Author(s): Mangano K, Nicoletti A, Patti F, Donia M, Malaguarnera L,  et al.

Critical role of preproenkephalin in experimental autoimmune  encephalomyelitis

Author(s): Weir C1, McNeill A, Hook S, Harvie M, La Flamme AC, et al. 

The immunoregulatory abilities of polymorphonuclear neutrophils in  the course of multiple sclerosis

Author(s): Ziaber J, PaÅ›nik J, Baj Z, Pokoca L, Chmielewski H, et  al.

Structural analysis of neprilysin with various specific and potent inhibitors

Author(s): Oefner C, Roques BP, Fournie-Zaluski MC, Dale GE

The biology  of the opioid growth factor receptor (OGFr)

Author(s): Zagon IS, Verderame MF, McLaughlin PJ

Opioid growth factor suppresses expression of experimental autoimmune  encephalomyelitis

Author(s): Zagon IS, Rahn KA, Bonneau RH, Turel AP, McLaughlin PJ